title: Diagnosis or drug? Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine?
authors: Jim
authors: J
authors: Kling
mesh_terms: D019317:Evidence-Based Medicine / Q000191:economics / Q000379:methods*; D020022:Genetic Predisposition to Disease; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000191:economics / Q000379:methods*; D010597:Pharmacogenetics / Q000191:economics / Q000379:methods*